LIMBITROL DS Drug Patent Profile
✉ Email this page to a colleague
When do Limbitrol Ds patents expire, and what generic alternatives are available?
Limbitrol Ds is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in LIMBITROL DS is amitriptyline hydrochloride; chlordiazepoxide. There are thirteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride; chlordiazepoxide profile page.
Summary for LIMBITROL DS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LIMBITROL DS at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LIMBITROL DS
US Patents and Regulatory Information for LIMBITROL DS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | LIMBITROL DS | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 016949-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIMBITROL DS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Chartwell Rx | LIMBITROL DS | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 016949-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
